Fundraising FoxSan Francisco · Pre-Seed–Series A · 19 people tracked
Also known as DOLBY FAMILY CAPITAL MANAGEMENT LLC · DOLBY FAMILY VENTURES LLC
Find your way into Dolby Family Ventures
Sign up to see every warm intro you have to Dolby Family Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dolby Family Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Since 2014, Dolby Family Ventures has funded frontier science and technology companies at the earliest stages, favoring a long-term, collaborative partnership model. Within life sciences it pursues two pillars: precision neuroscience (spanning neurodegeneration, psychiatry, and neurotech across therapeutics, devices, and diagnostics, with a focus on disease-modifying therapeutics) and life sciences platforms (de novo platforms, regenerative medicine, computational biology, and provider operations). A polymedicine approach guides its work on complex, high-burden diseases; it avoids non-platform companies in oncology, cardiovascular, and rare diseases. Beyond life sciences, the firm also invests in aerospace, digital deep tech, and climate tech, bringing scientific expertise and network connections to founders.
Source: firm website, verified Sep 29, 2026.
Team · 19 people
from the firm's website & public directories
What they invest in
from 97 of 143 portfolio companiesBiotech ×45AI & Machine Learning ×36Deep Tech ×33Healthtech ×31Medical Devices ×26Hardware ×20Digital Health ×17SaaS ×11
HQs:United States×75Australia×2Austria×1Switzerland×1Germany×1Netherlands×1
Who they back
founder profiles across 54 portfolio companiesFounding team size:solo founder×232 founders×133 founders×144+ founders×4
Where their founders studiedfrom 43 founders with education data
Massachusetts Institute of Technology ×5Harvard Medical School ×3Stanford University ×3Stanford University Graduate School of Business ×3UCLA ×3Caltech ×2Carnegie Mellon University ×2Cold Spring Harbor Laboratory ×2
What their founders studiedfrom 46 founders with field-of-study data
Engineering ×20Life Sciences ×15Business & Management ×6Chemistry ×5Medicine ×4Computer Science ×3Physics ×2
Where their founders worked beforefrom 47 founders with career history
Stanford University ×5Aurora ×2Berkeley Lab ×2Google ×2IBM ×2Lawrence Berkeley National Laboratory ×2Qualcomm ×2
Accelerator rootsportfolio companies that came through a program
29 founders hold a PhD · 5 hold an MBA (of 49 with degree data)
Investments · 143 tracked
founders shown can be your intro pathBy year:2025 · 52024 · 42023 · 62022 · 42021 · 62020 · 22019 · 52018 · 22017 · 62016 · 22015 · 32014 · 348 dated
Hyperfine develops diagnostic imaging and data solutions for patient care.
AI & Machine LearningDeep TechHealthtechMedical Devices
Jonathan Rothberg(Founder)Maria Sainz(President, Chief Executive Officer and Director)Brett Hale(Chief Administrative Officer, Chief Financial Officer, Treasurer and Corporate Secretary)Thomas Teisseyre(Chief Operating Officer)Jonathan M. Rothberg(Founder)
Co-investorsAltium CapitalColle Capital PartnersGV (Google Ventures)
Talkspace is an online mental health care platform that provides research-backed therapy and psychiatric services covered by insurance, allowing users to connect with licensed therapists and psychiatrists through text, audio, or video.
Digital HealthHealthtechMental Health
Oren Frank(Founder)inJon Cohen, M.D.inJon Cohen(Chief Executive Officer and Director)inRoni Frank(Founder)
Co-investorsCompoundHDS CapitalNorwest Venture PartnersQumra CapitalRevolutionRunway Venture Partners+15 more
Vaxcyte develops broad-spectrum vaccines to prevent bacterial infections, using a cell-free protein synthesis platform and synthetic chemistry techniques.
BiotechHealthtech
Grant Pickering(Founder)in
Co-investorsBioRock VenturesCTI Life Sciences Fund L.P.Foresite CapitalFrazier Life SciencesLongitude CapitalPivotal Life Sciences+3 more
AccuKnox provides automated adversarial testing for large language models, machine learning models, and cloud AI infrastructure to detect security vulnerabilities including prompt injection, jailbreaks, hallucinations, and misconfigurations.
AI & Machine LearningCloud ComputingCybersecurityEnterprise Software
Rahul Jadhav(Founder)in
Co-investorsAvanta VenturesDreamit VenturesNational Grid PartnersMDSV CAPITALOutliers VCZ5 Capital
AccuKnox provides an Application Security Posture Management (ASPM) platform that integrates vulnerability management, static and dynamic application security testing, software composition analysis, and infrastructure-as-code scanning to identify and prioritize security risks across the software development lifecycle for development and security teams.
AI & Machine LearningCloud ComputingCybersecurityDeveloper ToolsEnterprise Software
Co-investorsAvanta VenturesDreamit VenturesNational Grid PartnersSparq Capital (SFO)
Kuprion develops ActiveCopper materials and printable conductive inks used to manage heat in high-power, high-temperature electronic systems, serving electronics engineers and manufacturers across industries including semiconductor packaging, electric vehicles, and 5G communications.
HardwareNew MaterialsSemiconductorsSan Jose, US
Dr. Alfred Zinn(Founder)in
Co-investorsAlsop Louie PartnersStartup Capital Ventures
NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCleveland, US
Co-investorsBrain Trust Accelerator Fund
Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.
Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US
Nicholas Flanders(Founder)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)in
BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)
Co-investorsBreakout VenturesDCVC (Data Collective)Fifth WallAdvantage Partners Inc.Aera VCBreakout Labs+36 more
Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics.
BiotechHealthtechLongevityMedical DevicesLausanne, CH
Patrick Aebischer(Co-founder)Pénélope Andreux(Head of Research (mitochondrial research and development))inKlaus Dugi(Chief Medical Officer / Medical Leadership)inPeter(Business Development & Entrepreneurship Leadership)Leila(Operations Leadership)Anke Post(Chief Medical Officer / Neuroscience Leadership)
Co-investors+ND CapitalLevensohn Venture PartnersApollo Health Ventures
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Founder)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesEMV Capital+5 more
San Francisco, US
Todd Huffman(Founder)Megan Klimen(Founder)
BoardJoshua Wolfe(Director)Matt Ocko(Director)inAdam Goulburn(Director)inAdam Goulborn(Director)
Co-investorsComet LabsRecode VenturesDCVC (Data Collective)Dimension CapitalLux CapitalOS Fund
8i develops virtual and augmented reality technologies for human connection and immersive experiences, serving audiences across entertainment, education, training, and professional settings.
AI & Machine LearningDeep TechMedia & EntertainmentLos Angeles, US
Lincoln Gasking(Executive Officer, Director)Hayes Mackaman(CEO)
BoardJames D Robinson(Director)inScott Levine(Director)Scott Nolan(Director)in
Co-investorsAdvancit CapitalRight Click CapitalRRE VenturesSamsung NextFounders Fund
Acrigen develops precision gene editing systems based on CRISPR, using novel αCas and μCas nuclease libraries paired with engineered anti-CRISPR (ErAcr) proteins to reduce off-target edits.
BiotechDeep TechHealthtechKensington, US
Joseph Bondy-Denomy(Director)David Rabuka(Executive Officer, Director, Promoter)Karen Boezi(Director)
Co-investorsBerkeley Catalyst
Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials
Pavle Jeremic(Founder & CEO)inJay Zaveri(Co-Founder & President)
Co-investors4DX VenturesAbstract VenturesArtis VenturesBlue Bear VenturesBoxGroupCalm Ventures+12 more
all.health offers an Integrated Continuous Management (ICM) platform combining a clinical-grade wearable with an FDA-recognized system that collects 24/7 vitals and biometrics, screens for disease risk, and links patients to their care teams.
AI & Machine LearningDigital HealthHealthtech
Co-investorsMindset VentureMorpheus VenturesSignalFireReinvent Capital
Develops targeted MR imaging agents for early detection of Alzheimer's and other neurodegenerative diseases.
Co-investorsCentral Texas Angel Network
Astromecha designs engines, airframes, and flight systems for next-generation aerospace applications, including supersonic aircraft.
Advanced ManufacturingDeep TechHardwareSpace TechSan Francisco, US
Ian Brooke(CEO)in
Co-investorsAlumni VenturesAndreessen HorowitzBasecamp FundBlue Ivy VenturesEarthrise VenturesIndustrious Ventures+14 more
.jpeg){kind=logo}
A biotechnology company developing new therapies for patients with high unmet medical needs.
Biotech
Co-investorsLifeSci Venture PartnersSofinnova VenturesThe W FundViking GlobalCommodore CapitalFranklin Templeton+6 more
Atmosic designs ultra-low-power wireless connectivity and compute chips for connected devices, aiming to extend battery life or enable battery-free operation.
HardwareIoTSemiconductorsCampbell, US
David Su(Founder)inMasoud Zargari(Founder)in
Co-investorsClear VenturesSutter Hill VenturesWalden International
Denver, US
Co-investorsMatchstick VenturesPure VenturesTechstarsUrania VenturesCantos VenturesStout Street Capital+1 more
.png)
Atomwise uses artificial intelligence and machine learning to discover novel small-molecule drugs, with a current focus on developing treatments for immune and inflammatory diseases.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Izhar Wallach(Founder)inAbraham Heifets(Founder)inYan Zhao(Executive Officer)inStephen Worland(Executive Officer, Director)
BoardRobert Mittendorff(Director)inAdam Seabrook(Director)in
Co-investorsAurum Venture PartnersB Capital GroupCerity Partners VenturesCreative Destruction Lab (CDL)Draper AssociatesMission and Market+7 more
.jpeg){kind=logo}
August manufactures Wi-Fi-enabled smart locks and keypads that allow homeowners to remotely control door access and integrate with voice assistants like Alexa, Siri, and Google Assistant.
ConsumerHardwareIoTPropTechSan Francisco, US
Jason Johnson(Executive Officer, Director)in
BoardDavid Wu(Director)Michael Levit(Director)
Co-investorsBessemer Venture PartnersComcast VenturesCowboy VenturesGlobal BrainKDDI Open Innovation FundMaveron+8 more
Authentic Vision provides secure product digitalization solutions using holographic fingerprint technology and smartphone-based authentication to create copy-resistant product identities.
Advanced ManufacturingAI & Machine LearningCircular EconomyCybersecurityDeep TechEnterprise SoftwareFintechHardwareSaaSSalzburg, AT
Co-investorsJoint EffectsSmart Family Office
Developing microscale robots to deliver therapies locally to targeted brain disease areas.
Co-investorsAlumni VenturesBlue Ivy VenturesBold Capital PartnersCompoundDeep InsightFlucas Ventures+8 more
Cajal Therapeutics develops novel therapies through translating scientific advances into treatments for patients.
AI & Machine LearningBiotechDeep TechDigital HealthMedical DevicesSeattle, US
Andrew Dervan(Co-Founder and Co-Chief Executive Officer)inIan Peikon(Co-Founder and Co-Chief Executive Officer)inRob Hershberg(Co-Founder and Executive Chairman)in
Co-investorsLux CapitalThe Column Group
Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor.
Deep TechDigital HealthHealthtechMedical DevicesSilicon Valley, US
Kate Rosenbluth, PhD(President & Chief Innovation Officer)Kate Rosenbluth(Founder)inDeanna Harshbarger(Founder)in
Co-investorsAlumni VenturesAscension VenturesGlobal BrainGV (Google Ventures)Lightstone VenturesLux Capital+5 more
California Catalysts develops advanced materials and catalysts for hydrogen electrolysis using AI-driven discovery methods.
AI & Machine LearningCleantechEnergyNew MaterialsLos Angeles, US
Jim DiSanto(Co-founder, Board Director, Executive Consultant)inJourdan Urbach(CEO)
BoardNathan Lewis(Founder; Chief Scientific Advisor)
Co-investorsAcario InnovationMOL SwitchTSVCVoLo Earth VenturesMotus Ventures, Llc
Canaery develops a nose-computer interface that combines animal olfaction with neurotechnology and AI to detect substances and diagnose diseases.
AI & Machine LearningBiotechDeep TechHardwareMedical Devices
Gabriel(Chief Executive Officer)Peter(Chief Technology Officer)
BoardDmitry(Chief Science Advisor)
Co-investors15th RockFlorida Opportunity FundGood News VenturesNYU Innovation Venture FundBreakout VenturesKdT Ventures
Cato Digital builds a bare metal cloud platform focused on maximizing data center capacity utilization through low-cost, low-carbon computing solutions.
AI & Machine LearningCleantechCloud ComputingData & InfrastructureDeep Tech
Co-investorsCowles Ventures
Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US
Craig Thompson(Chief Executive Officer)inSagar Vaidya(Chief Medical Officer)inCarrie Ann Cook(Chief Business Officer)Mark Carlton(Chief Scientific Officer)inOttavio V. Vitolo(Chief Medical Officer)in
Co-investorsDementia Discovery FundForesite CapitalGV (Google Ventures)SV Life SciencesDementia DiscoveryLightstone Ventures+3 more
Cognition Therapeutics is a clinical-stage biotechnology company developing zervimesine (CT1812), an investigational once-daily oral small-molecule therapy designed to protect brain synapses by blocking toxic protein oligomers.
BiotechHealthtechPittsburgh, US
Susan Catalano(Executive Officer, Director)inSusan Catalano, Ph.D.(Co-founder)Lisa Ricciardi(Chief Executive Officer)inHarold Safferstein(Executive Officer, Director)
BoardNada Jain(Director)Franz Hefti(Director)
Co-investors3E Bioventures CapitalArieal Southeast Angel PartnersAtlanta Technology AngelsCowtown AngelsGolden SeedsHouston Angel Network+1 more
Cognitive Space develops AI-driven automation software for satellite operations, enabling constellation operators to scale while meeting operational requirements.
AI & Machine LearningDefense TechSaaSSpace TechHouston, US
Marc Bell(Co-Founder and CEO)Guy de Carufel(Founder)inDax Garner(CTO)inJeff Edwards(VP of Engineering)inHanna Steplewska(Executive Officer, Director)Jennifer Roberts(Director)in
Co-investorsArgon VenturesCapital InnovatorsCreative Destruction Lab (CDL)Draper AssociatesGlasswing VenturesGrit Ventures+10 more
Cogstate provides digital cognitive assessments, electronic clinical outcome assessment (eCOA) support, and endpoint data quality services for biopharmaceutical companies, academic institutions, and clinicians.
BiotechDigital HealthHealthtechMedical DevicesMelbourne, AU
Brad O'Connor(Chief Executive Officer)inDr. Ventola(Chief Science Officer)
Co-investorsEisai Innovation, Inc.
Casey Lynch(Founder)Kristen Gafric(Founder)Stephen Dominy(Founder)
Co-investorsPfizer Venture InvestmentsSofinnova Partners
Cquesta develops crop varieties with enhanced root systems to increase agricultural productivity and sequester carbon in soil.
AgTechBiotechCleantechClimate Tech
Andrew Baum(CEO)Tim Ulmasov(President and CSO)in
Co-investorsBezos Earth Fund
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)
Co-investorsArtis VenturesBailey Venture PartnersCasa Verde CapitalNoeticOMX VenturesPalo Santo VC+7 more
Density AI designs custom AI accelerators optimized for frontier-scale large language model inference, combining near-memory compute architecture with high-bandwidth memory density.
AI & Machine LearningDeep TechMountain View, US
Ben Floering(Founder)Bill Chang(Founder)Ganesh Venkat(Founder)
Co-investorsFirestreak VenturesHyphen Capitalimec.xpandNextGen Venture PartnersSouth Park CommonsStartX+5 more
Robotic systems and 3D printing company innovating at industrial scale to transform homebuilding.
Jack Oslan(Founder)Russel Varone(Founder)
Co-investorsAlumni VenturesPerot JainSuffolk TechnologiesAlpaca VCCalm VenturesGaingels+2 more
__Twitter.png)
DigiLens develops waveguide optics and holographic display technology using a proprietary material set combined with inkjet printing and a holographic contact copy process.
Deep TechHardwareNew MaterialsSunnyvale, US
Jonathan Waldern(Director)inChristopher Pickett(Executive Officer, Director)Patrick Suel(Director)Robert Young(Director)Thorsten Alexander Kern(Director)
BoardJim Whims(Director)
Co-investorsAlsop Louie PartnersBold Capital PartnersDiamond Edge VenturesIn-Q-TelNautilus Ventures Management Company (Us), LlcSony Ventures Corporation+2 more
Eargo was a hearing aid company that provided high-quality hearing aids and related care services.
HealthtechMedical DevicesMountain View, US
Raphael Michel(Founder)Christian Gormsen(Executive Officer, Director)William Brownie(Executive Officer)Peter Tuxen Bisgaard(Director)Daniel Shen(Founder)Florent Michel(Founder)
Co-investorsBirchmere VenturesLongitude CapitalMaveronNew Enterprise Associates (NEA)Peterson VenturesCrosslink Capital+4 more
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in
Co-investors20/20 HealthCare Partners LLCFlucas VenturesTachyon VenturesVU Venture PartnersAmgen VenturesBioverge+1 more
Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.
AI & Machine LearningBiotechMedical DevicesNew York, US
Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Founder)inMaria Luisa Pineda(Founder)in
Co-investorsDynamk CapitalHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationThird Kind Venture Capital
Esper provides device management software using DevOps principles for company-managed devices, automating provisioning and exception-based management across Android and other platforms.
Developer ToolsEnterprise SoftwareIoTBellevue, US
Shiv Sundar(Founder)inYadhu Gopalan(Founder)inJoe Lonsdale(Founder)Lilli Oetting(Founder)Maleka Momand(Founder)
Co-investorsGRIDS CapitalMadrona Venture GroupNimble PartnersPathbreaker VenturesRoot Ventures Manager, LlcUbiquity Ventures+5 more
Esper provides hyperspectral satellite imagery and geochemical analysis to identify critical minerals and alteration zones for mining exploration and environmental monitoring.
AgTechDeep TechSpace TechPatterson Lakes, AU
JoeyShoaib Iqbal(Founder)inPrzemyslaw Lorenczak(Founder)
Co-investorsCroc PitchInvestible Climate Tech FundNZVCScale Venture PartnersTechstars
Genemod offers a lab management platform that combines electronic lab notebook (ELN), LIMS, inventory, and equipment tracking in one data model, with AI agents that plan experiments, execute protocols across connected systems, and generate audit-ready records.
AI & Machine LearningBiotechHealthtechSaaSEdmonds, US
Jacob Lee(Executive Officer, Director, Promoter)inZachary Gut(Director)Michael Gregoire(Director)Jin Choe(Director, Promoter)Anil Arora(Executive Officer)
BoardNeil Sequeira(Director)in
Co-investorsAmino CapitalDefy Partnersfutureland venturesLDV Partners
-2.png)
General Sense develops detection technology that augments trained detection animals, aiming to identify molecular threats such as narcotics, crop diseases, human diseases, and bioweapons.
BiotechDeep TechDefense TechHardware
Co-investorsBreakout VenturesDraper AssociatesJuniperSOSV
.jpeg){kind=logo}
Herophilus develops neurological drug discovery by combining human brain models, scaled biology, and machine learning to identify and develop novel drugs for complex brain diseases.
AI & Machine LearningBiotechHealthtech
Co-investors515 VenturesKinled HoldingBoom CapitalBoom Capital Ventures
Hyperfine develops the Swoop portable, point-of-care MRI system for brain imaging without ionizing radiation, used in clinical and research settings for infants, children, and adults.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Jonathan Rothberg(Founder)in
Co-investorsDAYLI PartnersGV (Google Ventures)
ICON Aircraft designs, builds, and certifies Light-Sport Aircraft, notably the ICON A5, and offers customer sales, service, and flight training.
Advanced ManufacturingHardwareMobility & TransportationVacaville, US
Kirk Hawkins(Executive Officer, Director)Rich Bridge(Executive Officer)Thomas Wieners(Executive Officer)Katherine DeHoff(Executive Officer)Rodolfo (Rudy) Correa(Vice President, Operations)Amy Xu(Interim CFO & Corporate Secretary)
Co-investorsSeraph Group
Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens.
BiotechDigital HealthHealthtechMedical DevicesDublin, US
Michael W. Dunne(Executive Officer, Promoter)inCorey N. Fishman(Executive Officer, Director, Promoter)inJudith M. Matthews(Executive Officer, Promoter)Jeff Schaffnit(Executive Officer)
BoardBrenton K. Ahrens(Director)Ronald M. Hunt(Director)
Co-investorsBay City CapitalCanaan PartnersSofinnova VenturesAdvent Life SciencesFrazier Life SciencesSofinnova Venture Partners
Kebotix uses artificial intelligence, machine learning, and laboratory automation to discover and develop new materials and molecules.
AI & Machine LearningDeep TechNew MaterialsCambridge, US
Dennis Sheberla(Executive Officer)inSemion Saykin(Executive Officer)Alan Aspuru-Guzik(Executive Officer)inAshish Kulkarni(Chairman and CEO)in
BoardTong Hui(Director)Andrew Krowne(Director)in
Co-investorsArcTern VenturesBantam GroupConstructor Capital USEmbark VenturesFlybridge Capital PartnersOne Way Ventures+6 more
Next-generation wireless connector delivering 6 Gbps over secure EHF transmission.
Campbell, US
Eric Almgren(Executive Officer, Director)Gordon Almquist(Executive Officer)
BoardAnthony Fadell(Director)Rahul Chaturvedi(Director)Surendra Mandava(Director)Don McKinney(Director)
Co-investorsIn-Q-TelSamsung Catalyst FundAlsop Louie PartnersIntel CapitalNeuberger Berman
LeoLabs operates a network of ground-based radars and an AI-enabled cloud platform that tracks and maps objects and activity in low Earth orbit.
AI & Machine LearningDefense TechSpace TechMenlo Park, US
Daniel Ceperley(Founder & Chief Operating Officer)inEdward Lu(Founder & Chief Technology Officer)Michael Nicolls(Founder)Tony Frazier(Chief Executive Officer)John Buonocore(Founder & Chief Engineer)
Co-investorsAlumni VenturesDefence TrailblazerHemisphere Ventures LLCMDSV CAPITALNZ Growth Capital PartnersSeraphim Space+6 more
Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease.
BiotechLongevityMedical Devices
Dr. Gill(Chief Scientific Officer)
Co-investorsEpidarex CapitalAMR Action FundBoehringer Ingelheim Venture Fund
Lightform develops design tools for projected augmented reality, combining computer vision and hardware to enable interactive visual experiences.
AI & Machine LearningDeep TechDeveloper ToolsHardware
Co-investorsComet LabsGen CapitalPresence CapitalTuesday CapitalAnorak VenturesLevensohn Venture Partners+2 more
M3 is an open source metrics platform, originally developed by Uber's Observability team in 2014, built around a purpose-built time series database (M3DB), a query engine, and ingestion/aggregation components.
Cloud ComputingData & InfrastructureDeveloper Tools
Co-investorsCardinia Ventures
Magnefy develops hybrid magnetic sensing and signal-processing hardware combined with AI/ML for monitoring critical infrastructure in harsh, real-world environments.
Deep TechHardwareIoTPalo Alto, US
Joseph Kao(CEO & Co-Founder)inDerrick Du(Founding Product Manager)inAsma Mahar(Head of Hardware - Sensors & Signal Processing)in
Co-investorsDangerous VenturesImpact Ventures Management Pty LtdStartXSunna Ventures
Magnus Medical develops SAINT, an FDA-cleared, accelerated form of TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, over a 5-day course.
BiotechDigital HealthMedical DevicesMental HealthBurlingame, US
Nolan Williams(Director)Christian Gormsen(Executive Officer, Director)inVikram Lamba(Executive Officer)in
BoardXingjuan Chao(Director)inAndrew Firlik(Director)inHeath Lukatch(Director)
Co-investorsJAZZ Venture PartnersRed Tree Venture
Medcrypt provides cybersecurity products and strategic consulting to medical device manufacturers to ensure their devices are secure by design and meet FDA regulatory requirements.
CybersecurityHealthtechMedical DevicesSaaSSan Diego, US
Eric Pancoast(CTO)inMike Kijewski(CEO)inVidya Murthy(VP of Operations)inWilliam Fenstermaker(Founder)Om Mahida(Engineer)Erin Murphree(talent acquisition)
Co-investorsEniac VenturesIntuitive VenturesY CombinatorSection 32Alumni VenturesAnzu Partners+10 more
MindImmune develops therapeutics targeting the immune drivers of neurodegenerative diseases such as Alzheimer's, focusing on immune cells that respond to amyloid plaques before they enter the brain.
BiotechHealthtechKingston, US
Robert B. Nelson(Executive Officer, Director)Frank S. Menniti(Executive Officer, Director)inStevin Zorn(Executive Officer, Director)inIsaac Stoner(CEO)in
BoardRichard G. Horan(Director)Reetika Bhardwaj(Director)in
Co-investorsPfizer Venture InvestmentsSlater Technology FundARCH Venture PartnersPfizer Ventures
Mojo Vision develops micro-LED technology, positioning it as a platform for AI infrastructure and next-generation displays.
Deep TechHardwareSemiconductors
Nikhil Balram(Chief Executive Officer)inMike Wiemer(Chief Technology Officer)inG. Aaron James(General Counsel)inDrew Perkins(Founder)Michael Deering(Founder)Michael Wiemer(Founder)
Co-investorsARC Angel FundArgonautic VenturesBold Capital PartnersDisney AcceleratorFlucas VenturesFusion+20 more
Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Kevan Shokat(Co-Scientific Founder & Chairman of the SAB)Thomas Südhof(Co-Scientific Founder & SAB Member)Seth Stratton(Director)Dirk Langdorf(Director)Nicholas Hertz(Executive Officer, Director)
Co-investorsBEVCSV Health InvestorsTwo Bear CapitalDementia Discovery FundKdT Ventures
Monument Biosciences is a biotechnology company developing disease-modifying drugs for Alzheimer's Disease and Related Dementias (ADRD).
BiotechDigital Health
Co-investorsElevate Ventures
Moove.ai applies machine learning to real-time connected vehicle data to assess transportation risk and build mitigation tools focused on road safety and efficiency.
AI & Machine LearningData & InfrastructureMobility & TransportationLafayette, US
Rafay KhaninJack Greco(Director)inSalman Dhanani(Director)Abdur Rafay Khan(Executive Officer, Director)
BoardLauren Deluca(Director)in
Co-investorsCortado VenturesMotivate Venture CapitalService Provider CapitalUber
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)inKaiyuan Yang(Founder)
Co-investorsArboretum VenturesDivergent CapitalFeatures Capital HoldingsPsyMed VenturesTMC Venture FundXEIA Venture Partners+6 more
Motiv makes a lightweight titanium smart ring that tracks fitness, sleep, and heart rate for everyday consumers.
ConsumerHardwareWellness & Fitness
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.
BiotechDeep TechHealthtechMedical DevicesSomerville, US
MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)in
Co-investorsDevice of Tomorrow CapitalEmpath VenturesFuture VenturesGreyMatterMana VenturesPioneer+4 more
NextSense makes Smartbuds, EEG earbuds with dry-contact sensors that measure brain activity and adapt audio in real time to increase deep sleep, meditation, and focus.
Digital HealthHardwareWellness & FitnessMountain View, US
Jonathan Berent(Founder & CEO | Board Director)inBradley Horowitz(Director)
BoardJohn Kuelper(Director)QuHarrison Terry(Director)
Co-investorsAscension VenturesGV (Google Ventures)Joy VenturesPrime Movers Lab
Niantic Labs develops mobile games and apps that encourage outdoor exploration and real-world community engagement through location-based gaming experiences.
ConsumerGamingSan Francisco, US
John Hanke(Founder)Phil Keslin(Founder)
BoardKenji Okubo(Director)
Co-investorsAir Street CapitalAloft VCBattery VenturesBonfire VenturesBreyer CapitalCapitalG+15 more
Niantic Spatial builds real-world foundation models for physical AI, offering capabilities to reconstruct geometrically accurate 3D digital twins, localize devices without relying on GPS via a Visual Positioning System, and interpret 3D environments.
AI & Machine LearningDeep TechRoboticsSan Francisco, US
John Hanke(Founder & Executive Chairman)inKatherine Richard-Dodson(Executive Officer)Christopher Chow(Executive Officer)Thomas Gewecke(Executive Officer)inInhi Cho Suh(Chief Executive Officer)in
BoardGilman Louie(Director)in
Co-investorsAlsop Louie PartnersJavelin Venture PartnersScopely
Numerion combines drug discovery expertise with machine learning and computational chemistry.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US
Alex Levy(Founder)inIzhar Wallach(Founder)inSteve Worland(CEO)inPamela Tsuruda(VP, Biology)Mark Sabat(VP, Medicinal Chemistry)inKate Stafford(VP, Machine Learning)in
Co-investorsB Capital GroupB4 CapitalColorcon VenturesDCVC (Data Collective)NEXT CanadaY Combinator+12 more
OKAPI:Orbits provides AI-based Space Traffic Management (STM) and Space Situational Awareness (SSA) software platforms along with consulting services for satellite operators.
AI & Machine LearningSaaSSpace TechBraunschweig, DE
Kristina Nikolaus(Founder)in
Co-investorsAmadeus Capital PartnersAPEX VenturesMatterwave VenturesHeadlineMunich Re VenturesVentech
Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Matt Angle(Founder and CEO)inRon Kelly(Director)Thomas Krummel(Director)Adam Kablanian(Director)
Co-investors15th RockAlpha EdisonAnthropy PartnersATEL VenturesCapital FactoryCloudStone Capital+26 more
Pharmatrophix is developing a small-molecule drug for Alzheimer's disease that acts upstream of amyloid, with Phase 2a trial imaging showing dose-dependent preservation of whole-brain connectivity.
BiotechHealthtechRaleigh, US
Frank M. Longo(Director)inAnne C. Longo(Executive Officer)in
BoardRobert Sims(Director)
Phase Four developed in-space electric and multi-mode satellite propulsion; its technology assets were sold in 2025.
Hawthorne, US
STEPHEN KISER(Executive Officer, Director)inSimon Halpern(Executive Officer, Director)
BoardStewart Alsop(Director)inTHOMAS J.A. LAVIN(Director)JAMES BRIDENSTINE(Director)
Co-investorsAlsop Louie PartnersAlumni VenturesAutochrome VenturesIndustrious VenturesNew Science VenturesVeteran Ventures Capital
Technology identifying supply chain sources using the environmental microbiome.
Co-investorsGolden SeedsJ-VenturesWorking Capital FundAgFunderBlackhorn VenturesBreakout Labs+4 more
Potato builds software that connects scientific research intent to laboratory execution, enabling research teams to accelerate the translation from experimental design to hands-on lab work.
AI & Machine LearningBiotechDeep TechSaaS
Merrit Savener(VP of Commercial)
Co-investorsAllen Institute for AI (AI2) IncubatorDraper AssociatesEnsemble VCAlumni VenturesBoost VCCPT Capital+6 more
Progentos develops small-molecule therapeutics to stimulate myelin regeneration in multiple sclerosis patients by activating oligodendrocyte progenitor cells.
BiotechDeep TechMedical DevicesWatertown, US
Dmitrij Hristodorov(Director)inChristopher Loose(Executive Officer, Director)Sanjay Magavi(Executive Officer)Marc-Olivier Turgeon(Director)in
BoardAleks Radovic-Moreno(Director)inDan Janney(Director)
Co-investorsAlta PartnersLongwood FundMission BiocapitalService Provider CapitalForbion
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Founder, QurAlis; Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Founder, Chief Executive Officer)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsALS Investment FundDroia VenturesInkefMC Healthcare VenturesMission BiocapitalMitsui Global Investment+8 more
Potato builds software that bridges scientific research and laboratory execution, enabling research teams to move from hypothesis to experiment to learning faster by automating the manual processes between scientific intent and real-world lab work.
AI & Machine LearningBiotechDeep TechSaaS
Merrit Savener(VP of Commercial)
Co-investorsAlumni VenturesDraper AssociatesRoble VenturesEnsemble VC
REGENT designs and manufactures Seaglider wing-in-ground-effect aircraft for regional coastal transportation and defense logistics, offering high-speed zero-emission travel between coastal cities and military applications.
Advanced ManufacturingCleantechClimate TechDefense TechHardwareMobility & TransportationSpace TechNorth Kingstown, US
Billy Thalheimer(Founder)inMichael Klinker(Founder)inMike Klinker(Founder)Tom Harari(Vice President Strategy \u0026 Corporate Development)inSusan Hendrix(Lead Technical Recruiter)Jody Simon(Sourcing Lead)
Co-investorsFounders FundAurum Venture PartnersDarco CapitalFuture Planet CapitalGlobal BrainGraph Ventures+31 more
Reservoir Neuroscience is developing therapeutics aimed at repairing the blood-brain barrier.
BiotechHealthtechSan Francisco, US
Aaron Friedman(Executive Officer)Vladimir Senatorov(Director)
BoardTracy Saxton(Director)James Summers(Director)Brian Slingerland(Director)
Co-investorsage1
Neuromodulation therapy for migraine relief.
Eindhoven, NL
Hubert Martens(Co-founder; Chief Executive Officer)Daniel Schobben(Co-founder; Chief Innovation Officer)Dr. Wim Pollet(Co-founder; Chief Medical Officer)
Co-investorsInkefInnovation IndustriesLevensohn Venture PartnersPanakes PartnersSHS CapitalThuja Capital
Sea Machines develops autonomous command and control technology and computer vision systems for maritime vessels.
Advanced ManufacturingAI & Machine LearningDefense TechHardwareIoTRoboticsBoston, US
Michael G. Johnson(Founder)in
Co-investorsAccompliceToyota VenturesEmerald Technology Ventures AgGeekdomLaunchCapitalLDV Capital+7 more
Sepion develops advanced polymer separator technology for batteries and other applications including water separation and materials recovery.
CleantechDeep TechEnergyNew MaterialsSilicon Valley, US
Peter Frischmann(CEO & Co-Founder)inBrett Helms(CSO & Co-Founder)in
BoardRandy Chan(Director)
Co-investorsACVC PartnersAlumni VenturesCreative VenturesFine Structures VenturesFoothill VenturesISV+3 more
Sharrow Marine designs and manufactures the patented SHARROW propeller, a bolt-on marine propulsion product that improves boat range, handling, vibration, and noise across a wide variety of boat and engine brands.
Advanced ManufacturingHardwareMobility & TransportationDetroit, US
Co-investorsWakestream Ventures
Sensor and AI platform delivering real-time on-tractor soil chemistry analysis for smart fertilizer application.
Co-investorsAg Ventures AllianceAgLaunch Accelerator
SOURCE develops space-grade solar panels and arrays for spacecraft applications including earth observation, space-object observation, positioning, and exploration missions.
EnergyHardwareSpace TechLongmont, US
Philip Keller(CEO and Co-Founder)inBryan Mazor(Co-Founder)in
Co-investorsAlpine Space Ventures
Strateos develops remote access laboratory software and automation platforms that enable scientists to design, execute, and analyze experiments through cloud-based robotics and control systems.
AI & Machine LearningBiotechDeep TechRoboticsSaaSMenlo Park, US
Chris Krueger(Executive Officer)inMark Fischer-Colbrie(Executive Officer, Director)inDavid Lynch, PhD(Chief Executive Officer)Marc Siladi(Chief Operating Officer)in
BoardJoshua Wolfe(Director)Armen Vidian(Director)in
Co-investorsDCVC (Data Collective)Lux CapitalBlueStone Venture PartnersThird Rock VenturesAlumni VenturesHarmonix Fund+6 more
Switch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Si-Ping Han(Secretary)inDeepshikha Datta(Chief Executive Officer and President)
BoardKevin Zhang(Director)Alicia Irurzun-Lafitte(Director)inDylan Morris(Director)in
Co-investorsBold Capital PartnersCRV (Charles River Ventures)FREEFLOWGlobal BrainOno Venture Investment, Inc.Upfront Ventures+3 more
San Francisco, US
Shashank Samala(Founder)Jeffrey McAlvay(Executive Officer, Director)Jesse Koenig(Founder)Jeff McAlvay(Founder)
Co-investorsAlumni VenturesGrit VenturesKeiretsu ForumLux CapitalPoint72 VenturesSQN Venture Partners, LLC+5 more
Tetra Therapeutics (Tetra Discovery Partners) was a discovery-based pharmaceutical company developing clinical programs including treatments for Fragile X Syndrome.
BiotechHealthtechFlorham Park, US
Co-investorsInvest Michigan
Tetra Discovery Partners (d/b/a Tetra Therapeutics) was a clinical-stage biopharmaceutical company whose clinical trials and research programs were acquired by Shionogi & Co., Ltd. in 2020 and are now managed by Shionogi's U.S. subsidiary.
Biotech
Co-investorsMichigan Capital Network
Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.
BiotechDigital HealthHealthtechMedical DevicesSacramento, US
Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in
BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)
Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsAngelini VenturesDementia Discovery FundMitsui Global Investment+2 more
Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease.
AI & Machine LearningBiotechDeep TechCambridge, US
Tuomas Knowles(Executive Director, Co-Founder & Chief Technology Officer)Samuel Cohen(Executive Director & Co-Founder)inG. Kelly Martin(Executive Chairman & Co-Founder)George Martin(Executive Officer, Director)inStephanie Torruella(Executive Officer)inPreet Makkar(Executive Officer)
Co-investorsNorthpond VenturesLifeforce CapitalMagnetic VenturesTaiho Ventures, LLC
Transition Metal Solutions applies microbial and biochemical methods to enhance copper extraction from low-grade ores, enabling more efficient recovery with reduced environmental impact for mining operations.
BiotechCleantechNew Materials
Co-investorsJuniperNew Climate VenturesIndieBioPossible Ventures
TripleBlind develops privacy and security software using quantum-safe and cryptographic methods, with two main products: Privacy Suite for HIPAA-compliant sharing of protected health data and SecuriKey, a software-only security module addressing account takeover attacks.
CybersecurityDigital HealthSaaSKansas City, US
Riddhiman Das(Executive Officer, Director)Greg Storm(Executive Officer, Director)inAndrew Krowne(Director)in
BoardThad Langford(Director)in
Co-investorsAlumni VenturesClocktower VenturesFlyover CapitalKCRise FundRolling Fun GPAccenture Ventures+4 more
Ubotica builds orbital AI that runs across satellites and ground systems to monitor the maritime domain, predicting where risk is rising, tasking satellites and sensors to investigate, and delivering actionable intelligence.
AI & Machine LearningDefense TechSpace Tech
Co-investorsAtlantic Bridge VenturesGreencode VenturesSeraphim Space
Ursa Major develops flight-proven aerospace and defense systems, including hypersonic engines, solid rocket motors, and space mobility solutions for military and defense applications.
Defense TechHardwareSpace TechBerthoud, US
Joe Laurienti(Founder)inNick Doucette(Co-Founder & Vice President, Strategic Operations)inDan Jablonsky(CEO)inChris Spagnoletti(Chief Executive Officer)in
Co-investorsAlpha EdisonAtento CapitalBalerion Space VenturesBrave CapitalCrosscourt VenturesEclipse Ventures+8 more
Colorado aerospace and defense manufacturer of rocket engines, solid rocket motors, hypersonic and in-space propulsion systems.
Berthoud, US
Joseph A. Laurienti, Jr.(Executive Officer, Director, Promoter)Nicholas Doucette(Executive Officer)David Gregory(Executive Officer)
BoardStewart Alsop(Director)in
Co-investorsAlsop Louie PartnersAlumni VenturesAlpha EdisonBlackRockEclipseExplorer 1 Fund+2 more
Vorticity develops computing hardware and software designed to accelerate physics simulations and scientific modeling for industries including energy, life sciences, and aerospace.
Advanced ManufacturingRoboticsSan Francisco, US
Chirath Neranjena(Founder)in
Co-investorsAlumni VenturesCambium CapitalY CombinatorAcequia Capital (AceCap)
AWS Wickr is an enterprise-grade secure communication platform offering end-to-end encrypted messaging, voice, and video collaboration for organizations handling sensitive information, with compliance certifications including FedRAMP High and DoD IL4/5.
CybersecurityEnterprise SoftwareSaaSChicago, US
Christopher Howell(Executive Officer)inJennifer DeTrani(Executive Officer)Nico Sell(Co-Founder & Chairman)Kara Coppa(Executive Officer)Braden Seely(Executive Officer)York Sell(Executive Officer)
Co-investorsAlsop Louie PartnersBreyer CapitalGen CapitalHacker.Capital LLCIronGate Capital AdvisorsLytical Ventures+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AccuKnoxAetherAltSpaceVRAnthologyAnthology BiotechnologiesArclight TherapeuticsAtomos Nuclear and Space CorporationAtomwise (now named Numerion Labs)AugustAZTherapiesBasis ScienceBeep NetworksCala HealthChirp MicrosystemCoformerAIDiscover EchoEcho LaboratoriesEntasis TherapeuticsEyefluencegoBaltoM3 BiotechnologyMixed DimensionsNativewavesNew MatterNoon HomePlethoraRovieroSharrow EngineeringSoundThinkingSource EnergyTetra Discovery PartnersTransitionUboticaUltraLeapViumYumanityYumanity TherapeuticsZebra Medical Vision
Exits · 10
3 IPOs · 7 acquisitions · showing 6HyperfineNASDAQ: HYPRTalkspaceNASDAQ: TALKVaxcyteNASDAQ: PCVXAugust Home Inc.acq. by Assa AbloyNianticacq. by Scopely, Inc.Viumacq. by Recursion Pharmaceuticals
Portfolio news
latest coverage across their companiesCognition Therapeutics · manilatimes.net · Sep 8, 2026
REGENT · svpost.com · Aug 27, 2026
Vaxcyte · manilatimes.net · Aug 27, 2026
Ubotica Technologies · finsmes.com · Jul 2, 2026
Sepion · finsmes.com · Apr 17, 2026
Niantic Spatial · geekwire.com · Apr 7, 2026
Genemod · genemod.net · Mar 19, 2026
Frequently asked questions
- How many investments has Dolby Family Ventures made?
- Dolby Family Ventures has 143 tracked investments, 10 of which have exited, including 6 dated in the last 24 months.
- What stage does Dolby Family Ventures invest at?
- Dolby Family Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Dolby Family Ventures focus on?
- Dolby Family Ventures focuses on AI & Machine Learning, Biotech, Climate Tech, Cybersecurity, Deep Tech, Digital Health, Hardware, Healthtech, Medical Devices, New Materials, Semiconductors, Space Tech.
- Where is Dolby Family Ventures located?
- Dolby Family Ventures is headquartered in San Francisco, US.
- Does Dolby Family Ventures lead rounds?
- Dolby Family Ventures typically participates in rounds rather than leading them.
- Who does Dolby Family Ventures co-invest with?
- Dolby Family Ventures most often shares deals with Alumni Ventures, Alsop Louie Partners, Y Combinator, among 318 tracked co-investors.
- What size deals does Dolby Family Ventures back?
- Across 18 deals with disclosed amounts, Dolby Family Ventures has joined rounds of $3M – $85M (median $19.5M).
Images
Co-investors · 21
Alsop Louie Partners is a venture capital firm that invests in technology companies, emphasizing an approach it calls 'Venture Humanism' — backing accountable technologies designed with built-in safeguards to advance prosperity, equality, and longevity.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.
Founders Fund is a venture capital firm that backs technology companies building transformative products.
Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies aligned with Sanofi's mission of advancing human health.
SV Health Investors is a global private equity and venture capital platform dedicated to healthcare, running specialized funds across biotechnology (including dementia), healthcare growth equity, and medtech.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Susa Ventures operates two early-stage technology funds that invest in companies leveraging data, network effects, and economies of scale.
Tuesday Capital (formerly CrunchFund) is an early-stage venture firm founded in 2011 that backs founders building technology companies, providing hands-on support beyond capital.
Joanne Wilson is an early-stage angel investor and entrepreneur with a portfolio of over 140 companies, with emphasis on supporting female founders and mission-aligned businesses.
▶9 more co-investors
Anorak VenturesPresence CapitalAdvent Life SciencesUltratech Capital PartnersGoat CapitalTeam8SR One Capital ManagementCity LightJMI Equity
Firms observed investing alongside Dolby Family Ventures, from public investor directories. Shared companies are the overlap with Dolby Family Ventures's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Cambridge Angels is a UK business angel network that has been providing capital and operational support to entrepreneurs since 2001, backing more than 150 companies.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.